aviscumine
Term · Oncology and biomedicine · MLC-T-ONC-011825
A recombinant protein that inactivates the ribosome with potential antineoplastic and immunomodulating activities. Aviscumine binds to the cell surface sialyltransferase CD75 and is internalized; intracellularly, aviscumine cleaves an adenine-specific N-glycosidic bond on the 28S ribosomal subunit, which may result in tumor cell apoptosis. This agent has also been shown to activate natural killer (NK) cells, induce cytokine receptor expression, and stimulate the release of cytokines. CD75 is expressed on mature B cells and subsets of T cells and erythrocytes.
| Identifier | MLC-T-ONC-011825 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | toxin ML-I (mistletoe lectin I) (Viscum album) |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011825",
"term": "aviscumine",
"field": "Oncology and biomedicine",
"definition": "A recombinant protein that inactivates the ribosome with potential antineoplastic and immunomodulating activities. Aviscumine binds to the cell surface sialyltransferase CD75 and is internalized; intracellularly, aviscumine cleaves an adenine-specific N-glycosidic bond on the 28S ribosomal subunit, which may result in tumor cell apoptosis. This agent has also been shown to activate natural killer (NK) cells, induce cytokine receptor expression, and stimulate the release of cytokines. CD75 is expressed on mature B cells and subsets of T cells and erythrocytes.",
"synonyms": [
"toxin ML-I (mistletoe lectin I) (Viscum album)"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/aviscumine/"
}
Record 3,177 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.